temozolomide 20 MG Oral Capsule [Temodar]

RxCUI
261289
RxNorm name
temozolomide 20 MG Oral Capsule [Temodar]
Display name
temozolomide 20 MG Oral Capsule [Temodar]
Full name
temozolomide 20 MG Oral Capsule [Temodar]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TEMODARTEMOZOLOMIDEMerck Sharp & Dohme LLC046a9011-3911-4d3f-a15f-fbb56d5aad562026-02-20Warnings, Adverse reactionsExact identifier
rxcui: 261289

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
046a9011-3911-4d3f-a15f-fbb56d5aad56Temodar 20 MG Oral Capsule [PSN] · temozolomide 20 MG Oral Capsule [Temodar] [SBD] · Temodar 20 MG Oral Capsule [SY]340These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR ® (temozolomide) capsules, for oral use TEMODAR ® (temozolomide) for injection, for intravenous use Initial U.S. Approval: 199920260220
819571ea-b808-4fd8-93c7-1ea2e33d71cfTemodar 20 MG Oral Capsule [PSN] · temozolomide 20 MG Oral Capsule [Temodar] [SBD] · Temodar 20 MG Oral Capsule [SY]31These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR (temozolomide) Capsules TEMODAR (temozolomide) for Injection administered via intravenous infusion Initial U.S. Approval: 199920110209